(Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth ...

Trupanion Inc (TRUP) reports robust subscription growth and cash flow, while navigating retention and international market ...

With a rising number of pet owners and increased spending, the pet industry is demonstrating strong growth potential.

Trupanion reported mixed earnings with revenue exceeding expectations despite a shortfall in earnings per share (EPS).

Research analysts at William Blair cut their Q1 2025 EPS estimates for Trupanion in a note issued to investors on Thursday, ...

Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...

Trupanion, Inc.’s TRUP share price has dipped by 25.49%, which has investors questioning if this is right time to buy.

Trupanion (TRUP) delivered earnings and revenue surprises of -33.33% and 0.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Trupanion's Q4 2024 earnings show record margins, 20% subscription revenue growth, and innovative strategies for long-term objectives.

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Trupanion (TRUP – Research Report), with a price ...

Trupanion showed a significant turnaround with a net income of $1.7 million compared to a loss last year. Founded on a subscription-based business model, Trupanion generates predictable revenue by ...

Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results ...